← Back to feed

Eden Research

EDEN · AIM · Chemicals · mcap £19m today

All announcements

All RNS · 31 Key events · 19

06 Oct 26

Investor presentation

Eden BioSolutions plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, will provide an update to shareholders on the IMC platform, delivering the same presentation that was used at the Company’s AGM on 29 September 2026 on...
RNS 9807698 ↗
01 Oct 26

Change of Name
RNS 9800284 ↗
29 Sep 26

Result of AGM
RNS 9796474 ↗
29 Sep 26

AGM Statement

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, provides an update to shareholders ahead of its Annual General Meeting (‘AGM’) today at Cavendish's office, 1 Bartholomew Close, London EC1A 7BL at 10:00am BST.
RNS 9795216 ↗
28 Sep 26

US EPA approves expanded label for Mevalone

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for global agriculture, announces that the United States Environmental Protection Agency ("EPA") has approved an expanded...
RNS 9792574 ↗
17 Sep 26

Grant of Awards under LTIP PDMR Dealing
RNS 9776268 ↗
07 Sep 26

Notice of AGM
RNS 9759351 ↗
26 Aug 26

Final Results

Preliminary results for the 15 months ended 31 March 2026
RNS 9739916 ↗
25 Aug 26

Notice of Results
RNS 9737696 ↗
04 Aug 26

Regulatory approvals in Slovakia and Egypt

Eden extends its European footprint and secures its first authorisation for Mevalone® in North Africa
RNS 9702380 ↗
25 Jun 26

2026 Green Economy Mark

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, confirms that the Company has been included in the London Stock Exchange's 2026 Green Economy Mark cohort, comprising of 95 companies and funds whose products...
RNS 9635570 ↗
27 May 26

Directorate Change

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, announces that Derek McAllan has stepped down from the Board with immediate effect due to ill health.
RNS 9586487 ↗
28 Apr 26

Trading Update

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, provides the following unaudited trading update.
RNS 9540471 ↗
16 Apr 26

Holding(s) in Company
RNS 9524411 ↗
14 Apr 26

Holding(s) in Company
RNS 9520027 ↗
14 Apr 26

Holding(s) in Company
RNS 9519977 ↗
13 Apr 26

Holding(s) in Company
RNS 9517199 ↗
10 Apr 26

Completion of Conditional Placing and TVR

The Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce the successful completion of its Conditional Placing, as previously announced on 2 February 2026, having...
RNS 9513718 ↗
08 Apr 26

Satisfaction of Conditions of Conditional Placing

Further to the Company's announcement on 2 February 2026, the Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to confirm that all conditions relating to the Conditional...
RNS 9510725 ↗
02 Apr 26

Thymolflex EPA approval

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce that the Company's partner, Véto-pharma, has received regulatory approval from the US Environmental Protection Agency ("EPA") for...
RNS 9504393 ↗
19 Feb 26

Holding(s) in Company
RNS 9438984 ↗
19 Feb 26

Holding(s) in Company
RNS 9438818 ↗
18 Feb 26

Result of General Meeting and Total Voting Rights
RNS 9436220 ↗
05 Feb 26

Result of Retail Offer

The Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce that the Retail Offer launched on 2 February 2026 has now closed, raising gross proceeds of approximately...
RNS 9412160 ↗
02 Feb 26

Launch of Retail Offer

The Board of Eden Research plc (the "Company") is pleased to announce a retail offer via BookBuild (the "Retail Offer") of new ordinary shares ("Ordinary Shares") of £0.01 each in the capital of the Company (the "Retail Offer Shares") at an issue price of...
RNS 9402005 ↗
02 Feb 26

Proposed Placing and Subscription

THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY.
RNS 9401984 ↗
09 Jan 26

Novellus+ Regulatory Authorisation in Chile

Eden receives its first authorisation in South America, in one of the world's largest wine-exporting markets
RNS 9342860 ↗
07 Jan 26

Mevalone Label Extension in France

Mevalone® approved in France for use on grapes against downy and powdery mildew
RNS 9337503 ↗
18 Dec 25

Appointment of Syngenta as Distribution Partner

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, is pleased to announce the appointment of Syngenta Crop Protection AG ("Syngenta") as the Company's exclusive distribution partner for professional uses in...
RNS 9304982 ↗
20 Nov 25

3LOGY Label Extension in Italy

3LOGY® has been approved in Italy for use across an additional range of new crops and a number of new disease targets.
RNS 9245446 ↗
17 Nov 25

Ecovelex 2025 Approval in Italy

Ecovelex has been granted temporary authorisation in Italy, providing farmers with continued access to sustainable maize seed treatments to repel birds for the 2026 growing season
RNS 9236564 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.